⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
globenewswire.com
ALGS
Non-Alcoholic Steatohepatitis (NASH/MASH) - Drug Pipeline Insight 2026 | 75+ Candidates Across 70+ Companies Drive Licensing and Investment Opportunities
globenewswire.com
NVO
VKTX
GSK
ALGS
Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors
globenewswire.com
ALGS
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
globenewswire.com
ALGS
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS